Select Medical (NYSE:SEM) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.07-1.13 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.11. The company issued revenue guidance of $5.375-5.425 billion, compared to the consensus revenue estimate of $5.41 billion.Select Medical also updated its FY 2019
Pre-Market guidance to 1.07-1.13 EPS.
A number of analysts have recently issued reports on SEM shares. ValuEngine downgraded shares of Select Medical from a buy rating to a hold rating in a report on Thursday, November 14th. Deutsche Bank started coverage on shares of Select Medical in a report on Monday, September 16th. They set a buy rating and a $22.00 target price for the company. Finally, Credit Suisse Group set a $18.00 target price on shares of Select Medical and gave the company a hold rating in a research report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of $18.50.
SEM opened at $21.97 on Tuesday. Select Medical has a 52-week low of $12.96 and a 52-week high of $22.60. The firm has a market capitalization of $2.97 billion, a PE ratio of 21.33, a PEG ratio of 1.42 and a beta of 1.33. The company has a debt-to-equity ratio of 4.61, a quick ratio of 1.21 and a current ratio of 1.21. The business’s 50-day simple moving average is $19.43 and its 200 day simple moving average is $16.73.
Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.21 by $0.12. The firm had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.31 billion. Select Medical had a return on equity of 15.97% and a net margin of 2.62%. The business’s revenue was up 9.9% compared to the same quarter last year. During the same period last year, the company earned $0.23 earnings per share. On average, research analysts forecast that Select Medical will post 1.12 earnings per share for the current year.
In other Select Medical news, EVP Michael E. Tarvin sold 55,000 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $21.03, for a total transaction of $1,156,650.00. Following the transaction, the executive vice president now owns 356,777 shares of the company’s stock, valued at $7,503,020.31. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO David S. Chernow sold 3,020 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $18.02, for a total value of $54,420.40. Following the completion of the sale, the chief executive officer now owns 970,260 shares in the company, valued at approximately $17,484,085.20. The disclosure for this sale can be found here. Insiders sold 265,209 shares of company stock valued at $5,183,730 over the last three months. 19.50% of the stock is owned by company insiders.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Story: Correction
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.